How can we improve our nation’s liver health?

Join us in shedding light on fatty liver disease! Your insights can drive crucial research and awareness. Take our survey today! Start here➡️ surveymonkey.com/r/5SNG3WD
#FattyLiverAwareness #MASHResearch #LiverHealth #patientvoice #livertwitter #MetALD #MASLD

Help us understand fatty liver disease! Take our quick survey and be a part of the solution. Your insights matter! Please use this link and share it with others! ➡️surveymonkey.com/r/5SSK3DL #FattyLiverAwareness #MASLDResearch #livertwitter #HealthyLiving #LiverAwareness

The service being held Community Bible Church in San Antonio, Texas, today to honor and celebrate the remarkable life of Dr. Stephen Harrison via FattyLiverAlliance on behalf of the Harrison family→tinyurl.com/5eeme9v9 #RIPStephen #livertwitter #MASLD #MASH

The service being held Community Bible Church in San Antonio, Texas, today to honor and celebrate the remarkable life of Dr. Stephen Harrison via FattyLiverAlliance on behalf of the Harrison family→tinyurl.com/5eeme9v9 #RIPStephen #livertwitter #MASLD #MASH

We were asked, on behalf of the family to share this link to Dr. Stephen Harrison's funeral service today. It starts at 10:45am PST.

We again send our very best to the family in this difficult time.

AASLD EASLnews CASL Alina Allen Jörn Schattenberg ISGlobal…

A gluten-free diet leads to significant improvements in liver and metabolic parameters, as well as patient-reported outcomes in #MASLD .
onlinelibrary.wiley.com/doi/10.1111/ap…

We are deeply saddened by the passing of Dr. Stephen Harrison, a true pioneer in hepatology. His legacy in advancing liver disease treatment lives on. Our heartfelt condolences go out to his loved one➡️rb.gy/6i8nds #livertwitter

With deep sadness, AASLD recognizes the passing of a great leader in the field. Dr. Stephen Harrison leaves behind an incredible legacy, particularly in NASH/MASH. Thank you Drs. Rinella, Tetri, and Brunt for your moving tribute, which you can read here: aasld.org/col-stephen-ha…

Living with steatotic (fatty) liver disease? Share your journey in our 2024 survey and shape the future of liver care. Your voice matters! All responses are confidential. Start here➡️rb.gy/xt7cth
#patientvoice #liverhealth #livertwitter #MAFLD #MetALD #MASH #NASH

We are saddened by the sudden loss of our colleague Stephen Harrison, especially on the heels of his work that led to the first treatment for #MASH . Watch him discuss his hopes for resmetirom & patients. Our deepest condolences to his family. #livertwitter bit.ly/3JxDZEO

RIP big brother! Stephen last few days were filled with what he loved most. He was writing a piece about Resmetirom use and was pushing it w his close friends throughout the weekend. He passed from natural causes on Tuesday. His legacy will continue and we will all miss him…

GHASSA is saddened by the loss of a giant of Hepatology and a pioneer of MASLD work. May his dear soul rest in eternal peace. Our condolences to his family, friends and colleagues.

We’ve lost a friend and colleague who has had a monumental impact on MASH. Stephen brought charisma, endless energy, and joy along with deep knowledge and insights in MASH.
He had a magnetic force and we were all better for having been pulled into his orbit.

Henry - thank you for this. Stephen’s work will change the lives of so many patients for the better. He was such a wonderful human. AASLD EASLnews ALF Great Lakes Robert Mitchell-Thain💙💛 Jeffrey V. Lazarus

The patient advocacy community is shocked and deeply saddened by the sudden loss Dr. Stephen Harrison. A visionary in hepatology, Dr. Harrison foresaw many critical advancements and led the groundbreaking clinical studies that delivered the first U.S. FDA approved treatment for…

Saddened to hear about the untimely passing of Stephen Harrison, a giant who has moved the #MASLD field in leaps, not steps, towards better understanding and treatment. His legacy remains with us for many many years. RIP.

So sad about the passing of Stephen Harrison, one of the most influential leaders in hepatology, and a great person.

His legacy, including the first drug for MASLD, his talent and his kind demeanor will remain with us.

#livertwitter EASLnews AASLD

Stephen Harrison had a massive, positive, impact on the field. He produced landmarks in the epidemiology of NAFLD/MASLD, non-invasive testing, and he lead the trial that brought us the first FDA-approved drug

The patient advocacy community is shocked and deeply saddened by the sudden loss Dr. Stephen Harrison. A visionary in hepatology, Dr. Harrison foresaw many critical advancements and led the groundbreaking clinical studies that delivered the first U.S. FDA approved treatment for…